Rigel Pharmaceutical Inc. buy StockNews.com
Start price
23.09.23
/
50%
€1.00
Target price
23.09.24
-
Performance (%)
-22.75%
End price
24.09.24
-
Summary
This prediction is currently being closed. The prediction for Rigel Pharmaceutical Inc. disappoints with a performance of -22.75%. StockNews_com has a follow-up prediction for Rigel Pharmaceutical Inc. where he still thinks Rigel Pharmaceutical Inc. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - |
| iShares Core DAX® | -0,98 % | -4,72 % | 4,79 % |
| iShares Nasdaq 100 | 1,16 % | 1,88 % | 20,23 % |
| iShares Nikkei 225® | -1,59 % | -5,39 % | 31,35 % |
| iShares S&P 500 | -0,28 % | 0,33 % | 13,91 % |
Comments by StockNews_com for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for RIGL provided by MarketBeat
In the thread Trading Rigel Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Rigel Pharmaceutical Inc.
Stopped prediction by StockNews_com for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.37
12.03.24
12.03.24
-
12.03.25
12.03.25
-43.48%
13.03.25
13.03.25
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.67
27.10.23
27.10.23
-
27.10.24
27.10.24
8.91%
28.10.24
28.10.24